Related Experiment Video

Updated: Jun 12, 2026

Studying Cryptosporidium Infection in 3D Tissue-derived Human Organoid Culture Systems by Microinjection
05:31

Studying Cryptosporidium Infection in 3D Tissue-derived Human Organoid Culture Systems by Microinjection

Published on: September 14, 2019

[Epidemiological and clinical characteristics of intestinal microsporidiosis]

Sonia Anane1, H Attouchi, E Kaouech

  • 1Laboratoire de parasitologie-mycologie CHU La Rabta 15, rue Djebel-Lakhdhar 1007 Tunis, Tunisie. anane.sonia@planet.tn

Sante (Montrouge, France)
|May 21, 2010
PubMed
Abstract

Insights

Intestinal microsporidiosis primarily affects immunocompromised individuals, especially those with advanced HIV infection. Diagnosis requires specialized methods, and treatment depends on identifying the specific microsporidia species.

Area of Science:

  • Medical Parasitology
  • Infectious Diseases
  • Immunocompromised Host Infections

Context:

  • Intestinal microsporidiosis is an opportunistic infection prevalent in immunocompromised patients, particularly those with Human Immunodeficiency Virus (HIV).
  • This study retrospectively analyzed 572 immunocompromised patients over 13 years to understand the disease's characteristics and treatment outcomes.

Purpose:

  • To analyze the epidemiological and clinical features of intestinal microsporidiosis.
  • To evaluate available treatment options for intestinal microsporidiosis.

Summary:

  • A prevalence of 2.4% was observed, with 3.6% in HIV-infected patients and 1.4% in non-HIV infected patients.
  • The condition predominantly affected HIV-infected patients with CD4 counts below 100 cells/mm3, presenting with chronic diarrhea and dehydration.
  • Treatment varied, including symptomatic care and albendazole, with outcomes ranging from improvement to death.

Impact:

  • Highlights the importance of specialized diagnostic techniques for microsporidia detection.
  • Emphasizes that effective treatment necessitates accurate species identification.
  • Underscores the significant impact of intestinal microsporidiosis on patient morbidity and mortality, particularly in advanced AIDS cases.

More Related Videos

Studying Inherited Immunity in a Caenorhabditis elegans Model of Microsporidia Infection09:24

Studying Inherited Immunity in a Caenorhabditis elegans Model of Microsporidia Infection

Published on: April 6, 2022

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...